Results 61 to 70 of about 3,050,618 (255)
Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population [PDF]
Background Bowel cancer is common and is a major cause of death. Meta-analysis of randomised controlled trials estimates that screening for colorectal cancer using faecal occult blood (FOB) test reduces mortality from colorectal cancer by 16%.
Redman, VD +46 more
core +2 more sources
7-Ethyl-10-hydroxycamptothecin (SN38), a highly potent metabolite of irinotecan, has an anticancer efficacy 100–1000 folds more than irinotecan in vitro. However, the clinical application of SN38 has been limited due to the very narrow therapeutic window
Chao Yang +9 more
doaj +1 more source
Lignin‐mimicking protein methylation can enhance the efficacy and mitigate the toxicity of the classic FOLFOX chemotherapy regimen. ABSTRACT FOLFOX has served as the standard chemotherapy regimen for advanced stages, specifically in the treatment of pancreatic, colorectal, and bladder cancers.
Shiyao Song +14 more
wiley +1 more source
Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer [PDF]
<b>Background</b>: A pronounced tumour inflammatory infiltrate is known to confer a good outcome in colorectal cancer. Klintrup and colleagues reported a structured assessment of the inflammatory reaction at the invasive margin scoring low ...
Roxburgh, C.S. +4 more
core +1 more source
Colorectal cancer is primarily a disease of the developed world. The incidence rate has continued to increase over time, reflecting both demographic and lifestyle changes, which have resulted in genomic and epigenomic modifications.
Lorissa McDougall +15 more
doaj +1 more source
The Pro-Apoptotic Effects of Curcumin on HCT116 Colorectal Cancer Cells
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide, often originating from benign polyps in the colon and rectum that may become malignant if left untreated. While current treatments such as surgery, chemotherapy, and radiation are effective, they often come with severe side effects that impact patient quality of ...
Kuljeet Kaur +3 more
openaire +1 more source
Advanced Materials for Biologics Delivery to Brain Tumors
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng +4 more
wiley +1 more source
Background The efficacy of conventional chemoradiotherapy for colorectal cancer is often limited by resistance, with epithelial-mesenchymal transition being a key mechanism.
Lv Ge +11 more
doaj +1 more source
γ-Tubulin-containing abnormal centrioles are induced by insufficient Plk4 in human HCT116 colorectal cancer cells [PDF]
Cancer cells frequently induce aberrant centrosomes, which have been implicated in cancer initiation and progression. Human colorectal cancer cells, HCT116, contain aberrant centrioles composed of disorganized cylindrical microtubules and displaced appendages.
Kuriyama, R. +4 more
openaire +3 more sources
Oxaliplatin (OXA) is a first-line chemotherapeutic drug for the treatment of colorectal cancer (CRC), but acquired drug resistance becomes the main cause of treatment failure. Increasing evidence has shown that some natural components may serve as chemoresistant sensitizers.
Wang, Mengge +7 more
openaire +3 more sources

